Literature DB >> 12030388

Chlamydia pneumoniae infections in patients with community-acquired pneumonia in Slovenia.

Darja Kese1, Milan Cizman, Jozica Marin, Tatjana Avsic Zupanc.   

Abstract

It is well known that Chlamydia pneumoniae is an important respiratory pathogen. In this study, the prevalence of specific antibodies to C. pneumoniae in hospitalized patients with community-acquired pneumonia (943 adult females, 990 adult males and 185 children) was evaluated over a period of 7 y (1993-99). Two serum samples were obtained from all of the patients: 1 on admission and the other 3 weeks later. The specimens were tested for C. pneumoniae IgG, IgM and IgA antibodies by means of a microimmunofluorescence test. Acute infection with C. pneumoniae was determined in 9.4% of females and 13.1% of males. In children and adolescent patients, the microimmunofluorescence test showed recent infection in 8.6% of cases, with the highest prevalence occurring in the 11-15 y age group. The highest prevalence of C. pneumoniae pneumonia was found in 1995 and 1999: 15.4% and 13.6% respectively. The results obtained showed that C. pneumoniae is persistently present in the population of Slovenia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12030388     DOI: 10.1080/00365540110077399

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  2 in total

1.  Aetiology and clinical presentation of mild community-acquired bacterial pneumonia.

Authors:  B Beović; B Bonac; D Kese; T Avsic-Zupanc; S Kreft; G Lesnicar; J Gorisek-Rebersek; L Rezar; S Letonja
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-09-12       Impact factor: 3.267

2.  A new factor influencing pathogen detection by molecular assay in children with both mild and severe hand, foot, and mouth disease.

Authors:  Dong Zhu; Xiu-Ying Zhao; Yao Yao; Fang-Fang Dai; Han He; Run-Qing Li; Rong-Hua Jin; Lian-Chun Liang; Ning Li
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-25       Impact factor: 2.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.